CVKD - Company ID 0001937993
The table below shows Cadrenal Therapeutics, Inc.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash & equivalents | $4.01M | $10.00M | $8.40M | - |
| Short-term investments | - | - | - | - |
| Receivables | - | - | - | - |
| Inventory | - | - | - | - |
| Total current assets | $4.32M | $10.11M | $8.49M | $727.60K |
| Property, plant & equipment | $5.17K | $6.94K | $2.29K | $1.01K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill | - | - | - | - |
| Total assets | $4.33M | $10.12M | $8.52M | $778.17K |
| Accounts payable | $650.66K | $1.50M | $167.32K | $404.90K |
| Total current liabilities | $1.59M | $2.68M | $826.88K | $1.33M |
| Long-term debt | - | - | - | - |
| Total liabilities | $1.59M | $2.68M | $826.88K | $6.33M |
| Retained earnings | -$38.96M | -$25.72M | -$15.07M | -$6.71M |
| Total equity | $2.74M | $7.44M | $7.69M | -$5.55M |